Heavy Flu Season Helps Reckitt Beat Profit Forecasts

13.02.2013 - An unusually severe cold and flu season in the United States helped drive full-year profits higher at Britain's Reckitt Benckiser, maker of Strepsils throat lozenges and Mucinex...